Your browser doesn't support javascript.
SEMA: Antigen B-cell conformational epitope prediction using deep transfer learning.
Shashkova, Tatiana I; Umerenkov, Dmitriy; Salnikov, Mikhail; Strashnov, Pavel V; Konstantinova, Alina V; Lebed, Ivan; Shcherbinin, Dmitriy N; Asatryan, Marina N; Kardymon, Olga L; Ivanisenko, Nikita V.
  • Shashkova TI; Artificial Intelligence Research Institute, Moscow, Russia.
  • Umerenkov D; Sber AI Lab, Moscow, Russia.
  • Salnikov M; Artificial Intelligence Research Institute, Moscow, Russia.
  • Strashnov PV; Artificial Intelligence Research Institute, Moscow, Russia.
  • Konstantinova AV; Artificial Intelligence Research Institute, Moscow, Russia.
  • Lebed I; AI Center Block Services, Sber, Moscow, Russia.
  • Shcherbinin DN; Federal Research Centre of Epidemiology and Microbiology named after Honorary Academician N. F. Gamaleya, Ministry of Health, Moscow, Russia.
  • Asatryan MN; Federal Research Centre of Epidemiology and Microbiology named after Honorary Academician N. F. Gamaleya, Ministry of Health, Moscow, Russia.
  • Kardymon OL; Artificial Intelligence Research Institute, Moscow, Russia.
  • Ivanisenko NV; Artificial Intelligence Research Institute, Moscow, Russia.
Front Immunol ; 13: 960985, 2022.
Article in English | MEDLINE | ID: covidwho-2154722
ABSTRACT
One of the primary tasks in vaccine design and development of immunotherapeutic drugs is to predict conformational B-cell epitopes corresponding to primary antibody binding sites within the antigen tertiary structure. To date, multiple approaches have been developed to address this issue. However, for a wide range of antigens their accuracy is limited. In this paper, we applied the transfer learning approach using pretrained deep learning models to develop a model that predicts conformational B-cell epitopes based on the primary antigen sequence and tertiary structure. A pretrained protein language model, ESM-1v, and an inverse folding model, ESM-IF1, were fine-tuned to quantitatively predict antibody-antigen interaction features and distinguish between epitope and non-epitope residues. The resulting model called SEMA demonstrated the best performance on an independent test set with ROC AUC of 0.76 compared to peer-reviewed tools. We show that SEMA can quantitatively rank the immunodominant regions within the SARS-CoV-2 RBD domain. SEMA is available at https//github.com/AIRI-Institute/SEMAi and the web-interface http//sema.airi.net.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / COVID-19 Type of study: Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Front Immunol Year: 2022 Document Type: Article Affiliation country: Fimmu.2022.960985

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / COVID-19 Type of study: Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Front Immunol Year: 2022 Document Type: Article Affiliation country: Fimmu.2022.960985